UK approves 'landmark' breast cancer drug
A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run National Health Service, officials said on Friday.
Apr 11, 2025
0
23
Amino Acids, Peptides, and Proteins: News and Research on Neoplasm Proteins
MeSH tree: D12.776.624
New biomarkers to detect colorectal cancer found with AI and machine learning
Machine learning and artificial intelligence (AI) techniques and analysis of large datasets have helped University of Birmingham researchers to discover proteins that have strong predictive potential for colorectal cancer.
Jan 21, 2025
0
23
P-bodies sustain acute myeloid leukemia cell growth: Survival mechanism offers possibilities for new therapies
An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth.
Aug 21, 2024
0
47
FDA approves Leqselvi for severe alopecia
The U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata.
Aug 3, 2024
0
55
New tumor spatial mapping tool to assess cancer aggressiveness and personalize treatment
Scientists have developed a new AI tool that maps the function of proteins in a cancerous tumor, enabling clinicians to decide how to target treatment in a more precise way.
Feb 9, 2024
0
43
Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma
A new research perspective titled "Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma" has been published in Oncotarget.
Feb 7, 2024
0
40
Q&A: Behind the approvals—decades of research lead to a new generation of targeted cancer therapies
Last month, the U.S. Food and Drug Administration (FDA) approved the use of the drug capivasertib, in combination with a current cancer treatment called fulvestrant for patients with the most common type of breast cancer, ...
Dec 21, 2023
0
43
Study paints a new picture of colon development in mammals
University of Oregon researchers are filling in gaps in our understanding of the formation and growth the colon, a crucial part of the digestive system, by being among the first to apply modern molecular biology tools to ...
Dec 6, 2023
0
35
Key signaling protein identified as possible target for new therapies in hard-to-treat cancers
The unique signaling protein known as TRPM7 can stimulate and interact with an important cellular signaling hub called the AKT machinery, which is a well-known component of multiple cellular functions that drive growth and ...
Oct 26, 2023
0
43
Veratramine found to inhibit androgen-independent prostate cancer
The DGIST Core Protein Resources Center and Honam National Institute of Biological Resources announced that they have molecularly elucidated the mechanism by which veratramine, extracted from the wild island plant Veratrum ...
Sep 15, 2023
0
72
